84 related articles for article (PubMed ID: 2344825)
1. [Evaluation of the effectiveness of regional interleukin-2 dependent adoptive immunocytotherapy of mice with transplanted rhabdomyosarcoma].
Semenova-Kobzar' RA; Iudin VM; Kushko LIa; Iakhimovich LV; Berezhnaia NM
Eksp Onkol; 1990; 12(3):50-2. PubMed ID: 2344825
[TBL] [Abstract][Full Text] [Related]
2. [Method of assessing the functional activity of tumor-associated suppressor cells].
Iudin VM; Semenova-Kobzar' RA; Kushko LIa
Eksp Onkol; 1984; 6(6):37-41. PubMed ID: 6241144
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interleukin-2 acts as an adjuvant and helps to increase the efficacy of tumour vaccines.
Vondrys P; Símová J; Takácová S; Jandlová T; Bubeník J
Folia Biol (Praha); 1997; 43(1):39-40. PubMed ID: 9158948
[TBL] [Abstract][Full Text] [Related]
4. [Effect of exogenous interleukin 2 on the functional activity of immunocompetent cells in mice with transplanted tumors].
Semenova-Kobzar' RA; Kushko LIa; Iudin VM; Koval'chuk EV; Berezhnaia NM
Eksp Onkol; 1986; 8(2):39-42. PubMed ID: 2938929
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of cells participating in the adoptive transfer of tumor-associated suppressor activity].
Semenova-Kobzar' RA; Iudin VM; Kushko LIa; Koval'chuk EV; Berezhnaia NM
Eksp Onkol; 1985; 7(4):57-60. PubMed ID: 2931272
[TBL] [Abstract][Full Text] [Related]
6. An approach for the generation of effector lymphocytes from tumor-bearing hosts for the adoptive immunotherapy of established tumors.
Shu SY; Chou T
Prog Clin Biol Res; 1987; 244():27-37. PubMed ID: 3498953
[No Abstract] [Full Text] [Related]
7. [Characteristics of production and sorption of interleukin 2 by lymphoid cells during growth of transplanted sarcoma].
Kushko LIa; Semenova-Kobzar' RA; Iudin VM; Koval'chuk EV; Berezhnaia NM
Eksp Onkol; 1988; 10(1):34-7. PubMed ID: 3259499
[TBL] [Abstract][Full Text] [Related]
8. [Importance of the cyclophosphane administration regimen for its immunomodulating and antitumor effect in experimental chemotherapy].
Kovbasiuk SA
Vopr Onkol; 1985; 31(7):91-7. PubMed ID: 4024566
[TBL] [Abstract][Full Text] [Related]
9. [Effect of cyclophosphane on the suppressor activity of spleen cells in mice with transplantable tumors].
Kovbasiuk SA; Iudin VM; Kushko LIa; Semenova-Kobzar' RA
Eksp Onkol; 1985; 7(5):60-3. PubMed ID: 2933244
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues.
Ettinghausen SE; Lipford EH; Mulé JJ; Rosenberg SA
J Immunol; 1985 Aug; 135(2):1488-97. PubMed ID: 3891854
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
[TBL] [Abstract][Full Text] [Related]
12. Mast cells in regional lymph nodes responding to syngeneic and xenogeneic tumour MSVC and HeLa cell lines in BALB/c mice.
Włodarski KH; Mazur S; Rychlik G
Arch Immunol Ther Exp (Warsz); 1986; 34(1):1-5. PubMed ID: 3022665
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of tumour homograft immunity by lymph node cells undergoing graft-versus-host reaction.
Medzihradský J; Klobusická M; Koníková E; Babusíková O
Neoplasma; 1971; 18(3):233-40. PubMed ID: 4398444
[No Abstract] [Full Text] [Related]
14. Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2.
Rosenberg SA
J Biol Response Mod; 1984 Oct; 3(5):501-11. PubMed ID: 6389777
[TBL] [Abstract][Full Text] [Related]
15. Therapy of advanced solid tumors in mice using chemotherapy in combination with interleukin-2 with and without lymphokine-activated killer cells.
Kedar E; Ben-Aziz R; Shiloni E
Isr J Med Sci; 1988; 24(9-10):494-504. PubMed ID: 3264551
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
Matsumura T; Krinock RA; Chang AE; Shu S
Cancer Res; 1993 Sep; 53(18):4315-21. PubMed ID: 8364926
[TBL] [Abstract][Full Text] [Related]
17. Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumors.
Chou T; Bertera S; Chang AE; Shu S
J Immunol; 1988 Sep; 141(5):1775-81. PubMed ID: 3261761
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of repeated cycles of local IL-2 injections in mice carrying slowly growing tumour grafts.
Símová J; Bubeník J; Indrová M; Bubeníková D; Jandlová T
Folia Biol (Praha); 1993; 39(6):315-22. PubMed ID: 7926162
[TBL] [Abstract][Full Text] [Related]
19. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
Shu SY; Chou T; Rosenberg SA
J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816
[TBL] [Abstract][Full Text] [Related]
20. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
